tiprankstipranks
Takeda Pharmaceutical Co Ltd (TKPHF)
OTHER OTC:TKPHF
US Market
TKPHF
Takeda Pharmaceutical Co
RESEARCH TOOLSreports
Want to see TKPHF full AI Analyst Report?

Takeda Pharmaceutical Co (TKPHF) Financial Statements

35 Followers

Takeda Pharmaceutical Co Financial Overview

Takeda Pharmaceutical Co's market cap is currently $51.58B. The company's EPS TTM is $121.97; its P/E ratio is 46.52; and it has a dividend yield of 4.28%. Takeda Pharmaceutical Co is scheduled to report earnings on May 13, 2026, and the estimated EPS forecast is $0.38. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue¥ 4.51T¥ 4.58T¥ 4.26T¥ 4.03T¥ 3.57T
Gross Profit¥ 2.30T¥ 2.46T¥ 2.32T¥ 2.30T¥ 2.04T
Operating Income¥ 540.45B¥ 627.54B¥ 531.42B¥ 658.29B¥ 610.50B
EBITDA¥ 1.26T¥ 1.13T¥ 927.95B¥ 1.18T¥ 1.04T
Net Income¥ 191.76B¥ 107.93B¥ 144.07B¥ 317.02B¥ 230.06B
Balance Sheet
Cash & Short-Term Investments¥ 595.05B¥ 385.11B¥ 457.80B¥ 533.53B¥ 849.70B
Total Assets¥ 15.45T¥ 14.25T¥ 15.11T¥ 13.96T¥ 13.18T
Total Debt¥ 4.88T¥ 5.09T¥ 5.46T¥ 4.86T¥ 4.81T
Net Debt¥ 4.29T¥ 4.85T¥ 5.26T¥ 4.63T¥ 3.96T
Total Liabilities¥ 7.68T¥ 7.31T¥ 7.83T¥ 7.60T¥ 7.49T
Stockholders' Equity¥ 7.77T¥ 6.94T¥ 7.27T¥ 6.35T¥ 5.68T
Cash Flow
Free Cash Flow¥ 762.71B¥ 761.70B¥ 464.90B¥ 736.56B¥ 897.97B
Operating Cash Flow¥ 938.71B¥ 962.49B¥ 640.32B¥ 877.22B¥ 1.02T
Investing Cash Flow¥ -387.80B¥ -385.36B¥ -488.21B¥ -615.72B¥ -204.44B
Financing Cash Flow¥ -375.44B¥ -638.44B¥ -254.04B¥ -600.59B¥ -962.06B
Currency in JPY

Takeda Pharmaceutical Co Earnings and Revenue History

Income Statement >

Takeda Pharmaceutical Co Debt to Assets

Balance Sheet >

Takeda Pharmaceutical Co Cash Flow

Cash Flow >

Takeda Pharmaceutical Co Forecast EPS vs Actual EPS

Earnings >